Continue to Site

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Boston Scientific to acquire Preventice Solutions

Boston Scientific to acquire Preventice Solutions

By

Boston Scientific (NYSE:BSX) announced today that it entered into a definitive agreement to acquire Preventice Solutions.

Minneapolis-based Preventice designs mobile health solutions and remote monitoring services for patients with cardiac arrhythmias. Its wearables include the PatientCare platform and BodyGuardian family of monitors.

Preventice’s BodyGuardian monitors use a fully-integrated, cloud-based platform for clinical technicians and AI algorithms to provide insights leading to improved clinical diagnoses and outcomes. The company’s BodyGuardian Mini Plus, the newest system in its portfolio, features multiple electrode options to enhance rhythm detection while it is also waterproof, repositionable and can be used in all modalities of short-term and long-term monitoring.

Marlborough, Mass.-based Boston Scientific’s acquisition of the company includes an upfront cash payment of $925 million with an additional $300 million available in a potential commercial milestone payment.

The company has been an investor in Preventice since 2015 and currently holds an equity stake of approximately 22%. Boston Scientific expects that equity stake to result in a net payment of approximately $720 million upon closing, plus a milestone payment of up to approximately $230 million.

Preventice brought in net sales of $158 million in 2020, marking 30% growth year-over-year, according to a Boston Scientific news release.

“This acquisition will provide Boston Scientific with a foothold in the high-growth ambulatory electrocardiography space, which strongly complements our recent entrance into the implantable cardiac monitor market and will serve as an important component of our category leadership strategy in cardiac diagnostics and services – a nearly $2B market anticipated to grow double digits annually,” Boston Scientific senior VP & president of its rhythm and management business Scott Olson said in the release.
Olson added that Boston Scientific is confident that adding Preventice’s combination of technology and expertise can contribute to rapid growth in “highly-attractive markets” while aiding the company’s core cardiac rhythm management and electrophysiology businesses.
The companies expect the acquisition to close by mid-2021 and plan for it to be immaterial to adjusted earnings per share in 2021, accretive by at least 1¢ in 2022 and increasingly accretive thereafter.
“We have been humbled to provide thousands of physician practices with services based on near real-time clinical data to enable the diagnosis and management of more than one million cardiac patients, without needing to interrupt their daily activities,” Preventice CEO Jon Otterstatter said. “Boston Scientific has been a key investor in Preventice for more than five years and we believe the company has the commercial reach, diagnostics expertise and operational infrastructure to bring these advanced monitoring technologies to more patients worldwide.”
Analysts from Truist list Boston Scientific as a “buy” and cited the acquisition as a “good transaction,” noting the belief that the extended-wear monitoring space will remain “one of the fastest growth sub-segments of cardiac monitoring,” becoming even more competitive over time.
“We remain confident that the overall market can grow in the double digits, allowing multiple companies, Boston [Scientific] included, to be very successful in this space,” the analysis said.

In case you missed it

RSS From Medical Design & Outsourcing

  • Elevating Robotic Precision in Medical Devices: A Case Study by Omniseal Solutions™
    Unlock the secrets behind smoother robotic movements in medical devices with Omniseal Solutions™’ low friction sealing innovation. Our latest case study showcases how precision engineering meets medical excellence, ensuring optimal performance and reliability in robotic arm joints. By Clara Soueve Digital Customer Acquistion Specialist – Omniseal Solution™ Life Sciences Pioneering Low-Friction Seals for Robotic Arm… […]
  • How Medtronic evaluates its exposure to GLP-1 drugs
    Medtronic Chief Scientific, Medical and Regulatory Officer Dr. Laura Mauri drills into GLP-1 drug trial results to estimate their impact across the portfolio. The impact of glucagon-like peptide-1 (GLP-1) drugs like Ozempic and Wegovy on medtech manufacturing is one of the biggest uncertainties heading into 2024. Industry leaders like Medtronic, Stryker and Intuitive have faced… […]
  • Brain-computer interface lets ALS patient control home devices
    Researchers say they observed the successful translation of brain signals into computer commands with a brain-computer interface (BCI) implant. A team at Johns Hopkins surgically implanted the BCI on the brain of an ALS (amyotrophic lateral sclerosis) patient. They published their results, which showed the accurate translation of computer commands from brain activity, in Advanced Science.… […]
  • The 10 largest medtech employers of 2023 – and what their employees really think
    Employees at the 10 largest medtech employers in the world are finding a greater balance between work and life but are still frustrated by corporate bureaucracy. Those are just a few takeaways as Medical Design & Outsourcing compiled employees’ sentiments from reviews posted on Glassdoor. Total medtech jobs were down year-over-year in our 2023 Medtech… […]
  • Imperative Care CEO Fred Khosravi’s dream for medtech — and how to get there
    Medtech leader Fred Khosravi is betting on an innovative — and risky — approach to patient care. Imperative Care co-founder, Chair and CEO Fred Khosravi, a refugee of the Iranian Revolution who became an engineer and serial entrepreneur in the U.S., wants medtech to shift its focus from treating diseases to treating patients. He’s taking… […]
  • Can AI ‘move fast and cure things’ in healthcare?
    The entry of AI into healthcare is starkly different from the accepted adage of “move fast and break things” in consumerism. In episode 1 of AI Meets Life Sci, Kayleen Brown, managing editor at DeviceTalks, and Brian Buntz, pharma and biotech editor, discuss the opportunities, limitations, and direct impact of Ai in healthcare fields including… […]
  • Mytos raises $19M Series A to automate human cell manufacturing
    NEWS RELEASE: Mytos Announces $19M Series A Funding to Automate Human Cell Manufacturing and Further Accelerate Growth London, UK – November 30, 2023 – Mytos, an innovative leader in automated cell manufacturing, announced today it has closed $19M in Series A financing led by Buckley Ventures, with participation from IQ Capital and Wing VC. The… […]
  • Moticont releases 0.875-in. diameter linear voice coil servo motor
    NEWS RELEASE: Linear Voice Coil Servo Motor Just 0.875 in. in Diameter Has High Force-to-Size High Acceleration, and a 0.25 in. Stroke! Van Nuys, CA – Moticont has released the GVCM-022-013-01 Linear Voice Coil Servo Motor. This compact .875 in. (22.2 mm) diameter high speed, high force-to-size linear motor features high accuracy and high repeatability… […]
  • Wearable developer Empatica aims to develop new digital biomarkers
    Empatica Chief Medical Officer Dr. Marisa Cruz discusses advances in wearable technology and how new digital biomarkers could advance medtech. Dr. Marisa Cruz envisions a future where unobtrusive wearable devices with advanced sensors will continuously measure and record actionable biodata without patients having to lift a finger. Cruz is an endocrinologist and internist who serves… […]
  • Nordson Medical expands Pennsylvania operations
    NEWS RELEASE: Nordson Medical expands Easton, Pennsylvania operations into an additional facility Easton, Pennsylvania – November 29, 2023 – Nordson Medical, a global leader in the medical device components industry, is expanding its Easton, Pennsylvania operations into an additional facility less than two miles away. This expansion will allow an increased capacity of their fluorinated… […]
  • Medtech glossary: Medical device industry terms, abbreviations and acronyms
    Acronyms, abbreviations and definitions of medtech terms, devices and companies Medtech’s a complicated business, with its own industry abbreviations, acronyms and terms. Cut through the jargon with our constantly evolving glossary — and please suggest additions by emailing Managing Editor Jim Hammerand. 3D printing: A type of additive manufacturing used to make patient-specific anatomical models,… […]

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Copyright © 2023 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy